Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review

Critical Care

Volumn 16, Issue 1, 2012, Pages

  Xing, Katharine ^a   Murthy, Srinivas ^b   Liles, W Conrad ^c,d   Singh, Jeffrey M ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiopoietin; Biomarker; Coagulation; Endothelium; Sepsis

Indexed keywords

ANGIOPOIETIN; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CELL ACTIVATION; CLINICAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE ADHERENCE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; BLOOD; METABOLISM; PATHOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; SEPSIS;

EID: 84855816724     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11145     Document Type: Article

References (103)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
4. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
5. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010, 14:R15. 10.1186/cc8872, 2875530, 20144219.
6. Hotchkiss RS, Karl IE. Endothelial cell apoptosis in sepsis: a case of habeas corpus?. Crit Care Med 2004, 32:901-902. 10.1097/01.CCM.0000115264.93926.EC, 15090992.
7. Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE. Endothelial cell apoptosis in sepsis. Crit Care Med 2002, 30:S225-228. 10.1097/00003246-200205001-00009, 12004240.
8. Hemmer CJ, Vogt A, Unverricht M, Krause R, Lademann M, Reisinger EC. Malaria and bacterial sepsis: similar mechanisms of endothelial apoptosis and its prevention in vitro. Crit Care Med 2008, 36:2562-2568. 10.1097/CCM.0b013e31818441ee, 18679107.
9. Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001, 29:S21-27.
10. Matsuda N, Teramae H, Yamamoto S, Takano K, Takano Y, Hattori Y. Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol 2010, 298:H92-101. 10.1152/ajpheart.00069.2009, 19855068.
11. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002, 30:S302-312. 10.1097/00003246-200205001-00021, 12004252.
12. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83:536-545.
13. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
14. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?. Crit Care 2003, 7:130-138. 10.1186/cc1864, 270612, 12720559.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. 10.1136/bmj.39489.470347.AD, 2335261, 18436948.
16. Trzeciak S, Jones AE, Shapiro NI, Pusateri AE, Arnold RC, Rizzuto M, Arora T, Parrillo JE, Dellinger RP, . Emergency Medicine Shock Research Network (EMShockNet) investigators A prospective multicenter cohort study of the association between global tissue hypoxia and coagulation abnormalities during early sepsis resuscitation. Crit Care Med 2010, 38:1092-1100. 10.1097/CCM.0b013e3181cf6fbc, 20124888, Emergency Medicine Shock Research Network (EMShockNet) investigators.
17. Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, Christiaans SC, Bir ND, Pittet JF. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?. Ann Surg 2008, 247:320-326. 10.1097/SLA.0b013e318162d616, 18216540.
18. Cepkova M, Brady S, Sapru A, Matthay MA, Church G. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury. Critical Care 2006, 10:R126. 10.1186/cc5037, 1751077, 16956410.
19. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006, 203:1447-1458. 10.1084/jem.20060375, 2118329, 16702604.
20. Megarbane B, Marchal P, Marfaing-Koka A, Belliard O, Jacobs F, Chary I, Brivet FG. Increased diffusion of soluble adhesion molecules in meningitis, severe sepsis and systemic inflammatory response without neurological infection is associated with intrathecal shedding in cases of meningitis. Intensive Care Med 2004, 30:867-874. 10.1007/s00134-004-2253-1, 15067502.
21. Fujimi S, Ogura H, Tanaka H, Koh T, Hosotsubo H, Nakamori Y, Kuwagata Y, Shimazu T, Sugimoto H. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J Trauma 2002, 52:443-448. 10.1097/00005373-200203000-00005, 11901317.
22. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002, 17:451-458. 10.1097/00024382-200206000-00002, 12069179.
23. Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, Janin A, Tonnel A, Lassalle P. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 2000, 37:417-425. 10.1159/000025758, 11025405.
24. Giannoudis PV, Smith RM, Banks RE, Windsor AC, Dickson RA, Guillou PJ. Stimulation of inflammatory markers after blunt trauma. Br J Surg 1998, 85:986-990. 10.1046/j.1365-2168.1998.00770.x, 9692580.
25. McGill SN, Ahmed NA, Christou NV. Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation. Crit Care Med 1998, 26:296-300. 10.1097/00003246-199802000-00031, 9468168.
26. Kneidinger R, Bahrami S, Redl H, Schlag G, Robinson M, Weichselbraun I, Cremer J. Evaluation of a soluble E-selectin enzyme-linked immunosorbent assay under posttraumatic conditions. J Lab Clin Med 1996, 128:520-523. 10.1016/S0022-2143(96)90050-5, 8900296.
27. Hesselvik JF, Blomback M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 1989, 17:724-733. 10.1097/00003246-198908000-00002, 2502362.
28. van der Heijden M, van Nieuw Amerongen GP, van Hinsbergh VW, Groeneveld AB. The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients. Shock 2010, 33:263-268. 10.1097/SHK.0b013e3181b2f978, 19543148.
29. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010, 36:462-470. 10.1007/s00134-009-1726-7, 19956923.
30. Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005, 116:91-100. 10.1016/j.thromres.2004.09.022, 15907522.
31. von Heymann C, Langenkamp J, Dubisz N, von Dossow V, Schaffartzik W, Kern H, Kox WJ, Spies C. Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome. J Trauma 2002, 52:95-103. 10.1097/00005373-200201000-00017, 11791058.
32. Grad S, Ertel W, Keel M, Infanger M, Vonderschmitt DJ, Maly FE. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med 1998, 36:379-383. 10.1515/CCLM.1998.064, 9711425.
33. Rivers EP, Kruse JA, Jacobsen G, Shah K, Loomba M, Otero R, Childs EW. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007, 35:2016-2024. 10.1097/01.CCM.0000281637.08984.6E, 17855815.
34. Fang XL, Fang Q, Cai GL, Yan J. [Effect of fluid resuscitation on adhesion molecule and hemodynamics in patients with severe sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006, 18:539-541.
35. Boldt J, Papsdorf M, Piper SN, Rothe A, Hempelmann G. Continuous heparinization and circulating adhesion molecules in the critically ill. Shock 1999, 11:13-18.
36. Kuang X, Ma K, Duan T. [The significance of postburn changes in plasma levels of ICAM-1, IL-10 and TNFalpha during early postburn stage in burn patients]. Zhonghua Shao Shang Za Zhi 2002, 18:302-304.
37. Li PJ, Yang XH, Zhang LP, Cao W, Qin J, Yao W. [Clinical significance of soluble selectins and matrix metalloproteinases-9 in patients after successful cardiopulmonary resuscitation]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004, 16:137-141.
38. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007, 35:199-206. 10.1097/01.CCM.0000251640.77679.D7, 17110873.
39. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009, 31:348-353. 10.1097/SHK.0b013e318188bd06, 18791490.
40. Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A, Tsaganos T, Kotzampassi K. Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity. Cytokine 2008, 44:310-313. 10.1016/j.cyto.2008.09.003, 18952457.
41. Kranidioti H, Orfanos SE, Vaki I, Kotanidou A, Raftogiannis M, Dimopoulou I, Kotsaki A, Savva A, Papapetropoulos A, Armaganidis A, Giamarellos-Bourboulis EJ. Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes. Immunol Lett 2009, 125:65-71. 10.1016/j.imlet.2009.06.006, 19539650.
42. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 10.1186/cc7130, 2646310, 19025590.
43. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3:e46. 10.1371/journal.pmed.0030046, 1334221, 16417407.
44. Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, Anstey NM. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 2010, 14:R89. 10.1186/cc9020, 2911723, 20482750.
45. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008, 63:903-909. 10.1136/thx.2007.087387, 18559364.
46. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
47. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
48. Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011, 39:702-710. 10.1097/CCM.0b013e318206d285, 21242795.
49. Ebihara I, Hirayama K, Nagai M, Kakita T, Sakai K, Tajima R, Sato C, Kurosawa H, Togashi A, Okada A, Usui J, Yamagata K, Kobayashi M. Angiopoietin balance in septic shock patients with acute lung injury: effect of direct hemoperfusion with polymyxin B-immobilized fiber. Ther Apher Dial 2011, 15:349-354.
50. Page AV, Kotb M, McGeer A, Low DE, Kain KC, Liles WC. Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis 2011, 52:e157-161. 10.1093/cid/cir125, 21460306.
51. Shapiro N, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, Trzeciak S, Ngo L, Aird WC. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010, 14:R182. 10.1186/cc9290, 3219288, 20942957.
52. Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock 2011, 36:104-108. 10.1097/SHK.0b013e31821e4e04, 21522043.
53. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006, 34:532-537. 10.1097/01.CCM.0000198525.82124.74, 16424738.
54. Stief TW, Ijagha O, Weiste B, Herzum I, Renz H, Max M. Analysis of hemostasis alterations in sepsis. Blood Coagul Fibrinolysis 2007, 18:179-186. 10.1097/MBC.0b013e328040bf9a, 17287636.
55. Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin E, Hoffmann U, Weigand MA. Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 2009, 13:R93. 10.1186/cc7923, 2717465, 19538738.
56. Kinoshita M, Ono S, Mochizuki H. Neutrophil-related inflammatory mediators in septic acute respiratory distress syndrome. J Intensive Care Med 2002, 17:308-316.
57. Paterson RL, Galley HF, Dhillon JK, Webster NR. Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med 2000, 28:1047-1051. 10.1097/00003246-200004000-00022, 10809280.
58. Weigand MA, Schmidt H, Pourmahmoud M, Zhao Q, Martin E, Bardenheuer HJ. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 1999, 27:2656-2661. 10.1097/00003246-199912000-00008, 10628605.
59. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998, 157:776-784.
60. Boldt J, Muller M, Heesen M, Papsdorf M, Hempelmann G. Does age influence circulating adhesion molecules in the critically ill?. Crit Care Med 1997, 25:95-100. 10.1097/00003246-199701000-00019, 8989183.
61. Egerer K, Rohr U, Krausch D, Kox W. The circulating adhesion molecules sICAM-1 and sE-selection in patients with sepsis. Anaesthesist 1997, 46:592-598. 10.1007/s001010050442, 9304360.
62. Takakuwa T, Endo S, Inada K, Kasai T, Yamada Y, Ogawa M. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome. Res Commun Mol Pathol Pharmacol 1997, 98:43-52.
63. Boldt J, Muller M, Kuhn D, Linke LC, Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996, 22:122-128. 10.1007/BF01720718, 8857119.
64. Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 1995, 46:212-219.
65. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 1994, 22:651-657. 10.1097/00003246-199404000-00022, 7511496.
66. Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE. Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996, 24:1782-1786. 10.1097/00003246-199611000-00004, 8917025.
67. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T. Changes in adhesion molecule levels in sepsis. Res Commun Mol Pathol Pharmacol 1996, 91:329-338.
68. Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, Fowler AA. Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 1995, 151:1420-1427.
69. Presterl E, Lassnigg A, Mueller-Uri P, El-Menyawi I, Graninger W. Cytokines in sepsis due to Candida albicans and in bacterial sepsis. Eur Cytokine Netw 1999, 10:423-430.
70. Hynninen M, Valtonen M, Markkanen H, Vaara M, Kuusela P, Jousela I, Piilonen A, Takkunen O. Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care 1999, 14:63-68. 10.1016/S0883-9441(99)90015-1, 10382785.
71. Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, Karonen SL, Repo H. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci 1999, 97:529-538. 10.1042/CS19990073, 10545303.
72. Osmanovic N, Romijn FPHTM, Joop K, Sturk A, Nieuwland R. Soluble selectins in sepsis: Microparticle-associated, but only to a minor degree. Thromb Haemost 2000, 84:731-732.
73. Froon AH, Bonten MJ, Gaillard CA, Greve JW, Dentener MA, de Leeuw PW, Drent M, Stobberingh EE, Buurman WA. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Resp Crit Care Med 1998, 158:1026-1031.
74. Geppert A, Zorn G, Karth GD, Haumer M, Gwechenberger M, Koller-Strametz J, Heinz G, Huber K, Siostrzonek P. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med 2000, 28:2360-2365.
75. Simons RK, Hoyt DB, Winchell RJ, Rose RM, Holbrook T. Elevated selectin levels after severe trauma: a marker for sepsis and organ failure and a potential target for immunomodulatory therapy. J Trauma 1996, 41:653-662. 10.1097/00005373-199610000-00010, 8858024.
76. Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L, Martinelli N, Clausell N, Rohde LE, Biolo A. Ventricular dysfunction and dilation in severe sepsis and septic shock: Relation to endothelial function and mortality. J Crit Care 2011,
77. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008, 29:452-457. 10.1097/SHK.0b013e31815072c1, 18598002.
78. Knapp S, Thalhammer F, Locker GJ, Laczika K, Hollenstein U, Frass M, Winkler S, Stoiser B, Wilfing A, Burgmann H. Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immunol Immunopathol 1998, 87:139-144. 10.1006/clin.1998.4523, 9614928.
79. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Resp Crit Care Med 1997, 156:431-437.
80. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993, 150:644-654.
81. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Muller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 2007, 14:345-351. 10.1080/10623320701678326, 2430170, 18080871.
82. Karlsson S, Pettila V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E, Finnsepsis Study G. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg 2008, 106:1820-1826. 10.1213/ane.0b013e31816a643f, 18499616.
83. van der Flier M, van Leeuwen HJ, van Kessel KP, Kimpen JL, Hoepelman AI, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005, 23:35-38. 10.1097/01.shk.0000150728.91155.41, 15614129.
84. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GC. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 2007, 35:1677-1684. 10.1097/01.CCM.0000269034.86817.59, 17522579.
85. Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J, Pawlicki L. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007, 22:232-239. 10.1177/0885066607301444, 17722367.
86. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991, 33:222-227.
87. Pittet JF, Morel DR, Hemsen A, Gunning K, Lacroix JS, Suter PM, Lundberg JM. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991, 213:261-264. 10.1097/00000658-199103000-00014, 1358338, 1998407.
88. Yang K-Y, Liu K-T, Chen Y-C, Chen C-S, Lee Y-C, Perng R-P, Feng J-Y. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study. Critical Care 2011, 15:R11. 10.1186/cc9412, 3222041, 21219633.
89. Claus RA, Bockmeyer CL, Budde U, Kentouche K, Sossdorf M, Hilberg T, Schneppenheim R, Reinhart K, Bauer M, Brunkhorst FM, Losche W. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost 2009, 101:239-247.
90. Bockmeyer CL, Claus RA, Budde U, Kentouche K, Schneppenheim R, Losche W, Reinhart K, Brunkhorst FM. Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica 2008, 93:137-140. 10.3324/haematol.11677, 18166799.
91. Martin K, Borgel D, Lerolle N, Feys HB, Trinquart L, Vanhoorelbeke K, Deckmyn H, Legendre P, Diehl JL, Baruch D. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007, 35:2375-2382. 10.1097/01.CCM.0000284508.05247.B3, 17944029.
92. Garcia-Fernandez N, Montes R, Purroy A, Rocha E. Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb Res 2000, 100:19-25. 10.1016/S0049-3848(00)00306-6, 11053612.
93. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993, 103:1536-1542. 10.1378/chest.103.5.1536, 8486040.
94. Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001, 29:2325-2331. 10.1097/00003246-200112000-00016, 11801836.
95. Hovinga JAK, Zeerleder S, Kessler P, Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lammle B. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007, 5:2284-2290. 10.1111/j.1538-7836.2007.02743.x, 17764538.
96. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Luce JM, Montgomery AB, Marks JD, Matthay MA. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990, 86:474-480. 10.1172/JCI114733, 296749, 2384595.
97. Bajaj MS, Tricomi SM. Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intensive Care Med 1999, 25:1259-1266. 10.1007/s001340051054, 10654210.
98. Moss M, Ackerson L, Gillespie MK, Moore FA, Moore EE, Parsons PE. von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151:15-20.
99. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
100. Sankar J, Lodha R, Kabra SK. Management of septic shock: where do we stand?. Indian J Pediatr 2008, 75:1167-1169. 10.1007/S12098-008-0241-0, 19132319.
101. Yang KY, Liu KT, Chen YC, Chen CS, Lee YC, Perng RP, Feng JY. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study. Crit Care 2011, 15:R11. 10.1186/cc9412, 3222041, 21219633.
102. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1989, 17:389-393. 10.1097/00003246-198905000-00002, 2651003.
103. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995, 152:1818-1824.